» Articles » PMID: 2981780

A Re-examination of the Epstein-Barr Virus Carrier State in Healthy Seropositive Individuals

Overview
Journal Int J Cancer
Specialty Oncology
Date 1985 Jan 15
PMID 2981780
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

A panel of 24 healthy seropositive donors have been followed prospectively over a period of 15 months and monitored (1) for the level of EB virus shedding in the throat by means of a sensitive cord-blood transformation assay; (2) for the level of virus-infected B cells in the blood via a new in vitro protocol where "spontaneous transformation" can be seen to titrate against input cell number; (3) for anti-EB viral antibody titres and (4) for the prevailing level of virus-specific memory T cells in the circulation. Six donors shed easily detectable levels of EB virus into throat washings on every occasion of testing, whilst 16 other donors shed lower levels of virus detectable in throat washings on a majority (10 donors) or on a minority (6 donors) of test occasions; only 2/24 donors gave no evidence of virus shedding at any time. There was a direct relationship between the EB virus shedder status of an individual (i.e., the level of virus replication in the pharynx) and the number of infected B cells present in the circulation. These results indicate that chronic, usually low-grade, replication of the virus at some permissive site in the oro- and/or naso-pharynx is very often a stable accompaniment of the asymptomatic EB virus carrier state, and may indeed be essential for the long-term maintenance of that state.

Citing Articles

EBV-specific T-cell immunity: relevance for multiple sclerosis.

Behrens M, Comabella M, Lunemann J Front Immunol. 2025; 15():1509927.

PMID: 39776919 PMC: 11703957. DOI: 10.3389/fimmu.2024.1509927.


Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.

Thomas O, Haigh T, Croom-Carter D, Leese A, Wijck Y, Douglas M PLoS Pathog. 2024; 20(6):e1012177.

PMID: 38843296 PMC: 11156336. DOI: 10.1371/journal.ppat.1012177.


Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.

Edwards K, Schmidt K, Homad L, Kher G, Xu G, Rodrigues K Cell Rep Med. 2024; 5(6):101587.

PMID: 38781964 PMC: 11228584. DOI: 10.1016/j.xcrm.2024.101587.


EBV Association with Lymphomas and Carcinomas in the Oral Compartment.

Ward B, Schaal D, Nkadi E, Scott R Viruses. 2022; 14(12).

PMID: 36560704 PMC: 9783324. DOI: 10.3390/v14122700.


Performing nasopharyngeal swabs-Guidelines based on an anatomical study.

Pruidze P, Mincheva P, Weninger J, Reissig L, Hainfellner A, Weninger W Clin Anat. 2021; 34(6):969-975.

PMID: 34216513 PMC: 8426742. DOI: 10.1002/ca.23762.